Prostate Cancer
View Prostate Cancer Information from the National Cancer Institute
My Fox Chase Experience A Father's Motivation
Melvin Snyder joined Fox Chase's program for men at risk of developing prostate cancer because he thought it was the responsible thing. Since his father died of the disease, he wanted to be involved in a program that provided screening, counseling and other risk assessment services. More
Prostate Cancer Risk Assessment Program for men who have a family history or other risk factors for prostate cancer
Introducing the newest generation in robotic surgery technology:
da Vinci S
While its technological advantages are significant, your surgeon's skill and experience remain the most important elements for achieving superior surgical outcomes. More
MyBiopsy.org
Cancer diagnosis information for patients from the College of American Pathologists
Fox Chase Cancer Center is an internationally recognized leader in the treatment of prostate cancer. Our nationally ranked doctors provide a wide range of treatment options.
Your treatment at Fox Chase will be tailored especially for you and may include:
- Robotic-assisted laparoscopic (da Vinci) or open nerve-sparing surgery performed by our highly-skilled surgeons
- IMRT delivered by one of the nation's most experienced radiation oncology teams
- State-of-the-art brachytherapy
- The most advanced prostate cancer chemotherapy and hormone therapy provided by our experts in medical oncology
Prostate Cancer Clinical Trials
Fox Chase also designs and conducts investigational studies (clinical trials) of medicines and technologies for various stages of prostate cancer, giving our patients the most options for treatment. For patients with prostate cancer, we offer:
- A clinical trial using IMRT to reduce erectile dysfunction
- Studies examining different ways of administering hormone therapy
For more information about prostate cancer treatment and prevention at Fox Chase Cancer Center or to make an appointment, call 1-888-FOX CHASE (1-888-369-2427).

Print this Page
E-mail This Page
